18 June 2014

Fragment Events in 2014 and 2015 - midyear update

The year is nearly half over, but there are still some great events ahead, and 2015 is already shaping up nicely!

2014

July 19-22: Zing conferences is holding its first-ever Fragment Based Drug Discovery in Punta Cana, Dominican Republic. In addition to the amazing location there are more than two dozen great speakers, so definitely check this one out - there is still time to register by June 30.

August 10-14: The 248th ACS National Meeting will be held in the cool gray city of San Francisco, and there will be several presentations on fragments as well as what I believe will be the first session on PAINS.  

September 21-24: FBLD 2014 will be held in Basel, Switzerland. This marks the fifth in an illustrious series of conferences organized by scientists for scientists, the last of which was in San Francisco in 2012.  I believe this will also be the first major dedicated fragment conference in continental Europe. You can read impressions of FBLD 2010 and FBLD 2009. Also, if you're new to the field (or looking for a refresher) Rod Hubbard, Ben Davis, and I will teach an introductory workshop on Sunday, September 21.

October 8-10: CHI's 12th Annual Discovery on Target takes place in Boston, where it looks like there will be several talks relevant to readers of this blog. And on October 7, Teddy and I will be teaching a short course on targeting protein-protein interactions, which naturally includes fragments.

2015

February 17-18: Newly added! SELECTBIO is holding its Discovery Chemistry Congress in Berlin, Germany, with a number of talks on fragment-based lead discovery.

March 22-24: The Royal Society of Chemistry will be holding Fragments 2015 in Cambridge, UK, the fifth in the series organized by RSC-BMCS. You can read impressions of Fragments 2013.

April 21-23: CHI’s Tenth Annual Fragment-Based Drug Discovery will be held in San Diego. You can read impressions of this year's meeting here and here, last year's meeting here and here, the 2012 meeting here, the 2011 meeting here, and 2010 here. As this will be their ten-year anniversary, I think they're planning something big!

June 9-12: NovAliX will hold its second conference on Biophysics in Drug Discovery in Strasbourg, France. Though not exclusively devoted to FBLD, there is lots of overlap; see here, here, and here for discussions of last year's event.

December 15-20: Finally, the first ever Pacifichem Symposium devoted to fragments will be held in Honolulu, Hawaii. The Pacifichem conferences are held every 5 years and are designed to bring together scientists from Pacific Rim countries including Australia, Canada, China, Japan, Korea, New Zealand, and the US. There is lots of activity in these countries, and since travel to mainland US and Europe is onerous this should be a great opportunity to meet many new folks - in Hawaii no less! Abstract submissions will open in January.

Know of anything else? Add it to the comments or let us know!


1 comment:

Anjani Shah, Ph.D., Conference Director said...

Here is more information on the Boston/Fall 2014 and San Diego/Spring 2015 CHI (Cambridge Healthtech Institute) events; I produce the 'PPI' meetings at both events and the 'Fragments' meeting in San Diego:

Fall/Boston -- PPI meeting: Not only will Dan and Teddy be giving a short course before the meeting, but Teddy will also be giving a talk on using NMR for PPIs at the meeting. There will be a few other talks (such as one by Pamela Williams from Astex) that also discuss fragment approaches. This meeting is more 'discovery biology' focused than our spring PPI meeting, which is more medicinal chemistry oriented; but of course there will be a lot of overlap. The fall/Boston PPI meeting will spend more time on the PPIs cellular role and why they make good targets. The PPI meeting in Spring/San Diego focuses more on optimization of the lead compounds than validation of the PPI and initial discovery of compounds targeting it.

Also, as Dan mentioned, the Spring/San Diego event also has a dedicated meeting for 'Fragment Based Drug Discovery' -- that many people pair with the PPI meeting; each is a day and a half and are back-to-back.